SEPIDEH AMIN-HANJANI, M.D.
Medical Practice at Taylor St, Chicago, IL

License number

Illinois 036-109683

Personal information

See more information about SEPIDEH AMIN-HANJANI at radaris.com

Name

Address

Phone

Sepideh Amin-Hanjani

165 Canal St, Chicago, IL 60606

Organization information

See more information about SEPIDEH AMIN-HANJANI at bizstanding.com

Sepideh Amin-Hanjani MD

1801 W Taylor St, Chicago, IL 60612

Industry:

Neurosurgeon

Phone:

(312) 355-0510 (Phone)

Sepideh H. Amin-Hanjani

Professional information

See more information about SEPIDEH AMIN-HANJANI at trustoria.com

Dr. Sepideh Amin-Hanjani, Chicago IL - MD (Doctor of Medicine)

Specialties:

Neurosurgery

Address:

912 S Wood St SUITE MC799, Chicago 60612
(312) 996-9018 (Phone)

Certifications:

Neurosurgery, 2004

Awards:

Healthgrades Honor Roll

Languages:

English, Arabic

Hospitals:

912 S Wood St SUITE MC799, Chicago 60612
Presence Saints Mary and Elizabeth Medical Center - Division
2233 West Division St, Chicago 60622
Presence Saints Mary and Elizabeth Medical Center - Claremont
1431 North Claremont Ave, Chicago 60622

Education:

Medical School
Harvard Medical School
Graduated: 1994
Mass Genl Hospital Harvard Med School
Graduated: 1995
Massachusetts General Hospital
Graduated: 2000
Barrow Neurological Institute
Graduated: 2005

Sepideh Amin-Hanjani, Chicago IL

Specialties:

Neurosurgeon

Address:

1740 W Taylor St, Chicago, IL 60612
912 S Wood St, Chicago, IL 60612

Education:

Harvard Medical School - Doctor of Medicine*

Board certifications:

American Board of Neurological Surgery Certification in Neurological Surgery*

Method And System For Evaluating Vertebrobasilar Disease

US Patent:

7904136, Mar 8, 2011

Filed:

Feb 19, 2008

Appl. No.:

12/033399

Inventors:

Fady T. Charbel - River Forest IL, US
Fady Charbel, II - River Forest IL, US
Meide Zhao - Lisle IL, US
Anthony Curcio - River Forest IL, US
Sepideh Amin-Hanjani - Chicago IL, US

Assignee:

Vassol Inc. - River Forest IL

International Classification:

A61B 5/05

US Classification:

600419, 600410, 600411, 600504

Abstract:

A method and system are disclosed for evaluating symptomatic vertebrobasilar disease VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.

Method And System For Evaluating Vertebrobasilar Disease

US Patent:

2006017, Aug 3, 2006

Filed:

Feb 2, 2005

Appl. No.:

11/049618

Inventors:

Fady Charbel - River Forest IL, US
Meide Zhao - Lisle IL, US
Anthony Curcio - River Forest IL, US
Sepideh Amin-Hanjani - Chicago IL, US

International Classification:

A61B 5/05, A61B 5/02

US Classification:

600419000, 600483000, 600504000

Abstract:

A method and system are disclosed for evaluating symptomatic VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.

Regional Cerebral Volume Flow Using Quantitative Magnetic Resonance Angiography

US Patent:

2008014, Jun 19, 2008

Filed:

Sep 20, 2007

Appl. No.:

11/858424

Inventors:

Meide Zhao - Oswego, IL
Sepideh Amin-Hanjani - Chicago IL, US
Sean Ruland - Chicago IL, US
Anthony Curcio - River Forest IL, US
Lauren Ostergren - Ithaca NY, US
Fady T. Charbel - River Forest IL, US

International Classification:

A61B 5/026

US Classification:

600504

Abstract:

A method and system for evaluating the cerebral circulation of a patient is described. The arterial network of the brain is partitioned into a plurality of different regions where each region is supplied with blood by particular cerebral arteries. Volume flows into the regions are calculated from the measured volume flows of the cerebral arteries using quantitative magnetic resonance angiography. The cerebrovascular circulation of an individual patient may therefore be evaluated for the presence of disease by comparing the regional blood flows of the patient to normal values as obtained from population data.